OUR COMPANY

We’re the Company Behind OPTAVIA

Medifast is the company behind one of the fastest-growing health and wellness communities, OPTAVIA, which offers scientifically developed products, clinically proven plans and the support of independent OPTAVIA Coaches to help Customers achieve Lifelong Transformation, One Healthy Habit at a Time.

OUR APPROACH

3 Million Lives Impacted

Medifast has impacted more than 3 million lives through its Community of OPTAVIA Coaches, who teach Customers how to develop holistic healthy habits through the proprietary Habits of Health® Transformational System. Today, we are a market leader, by revenue, in the United States $7 billion weight management industry and publicly traded under MED on the New York Stock Exchange.

OUR APPROACH

2 Million Lives Impacted

Medifast has impacted more than 2 million lives through its Community of OPTAVIA Coaches, who teach Customers how to develop holistic healthy habits through the proprietary Habits of Health® Transformational System. Today, we are the market leader, by revenue, in the United States $7 billion weight management industry and publicly traded under MED on the New York Stock Exchange.
LEADERSHIP

“We’re a mission-driven organization that is making a real difference. In partnership with our independent OPTAVIA Coaches, we’re leading a movement that’s changing the paradigm of health and wellness as we know it. People are craving a holistic, supportive approach to managing health and wellbeing, and our Coaches are delivering just that.”

— Dan Chard, Chairman and Chief Executive Officer

LEADERSHIP
“We’re a mission-driven organization that is making a real difference. In partnership with our independent OPTAVIA Coaches, we’re leading a global movement that’s changing the paradigm of health and wellness as we know it. People are craving a holistic, supportive approach to managing health and wellbeing, and our Coaches are delivering just that.”

— Dan Chard, Chairman and Chief Executive Officer

AT A GLANCE

A Differentiated and Unique Model Centered on Independent OPTAVIA Coaches

Company Performance

Third Quarter 2025 Highlights

Medifast reported Q3 2025 earnings results, with revenue at the high end of the guidance range and EPS within the guidance range. ​ Productivity among active coaches is showing signs of stability as we move into the final quarter of the year.

Learn More
Company Performance

Evolving Corporate Strategy

Medifast is evolving from being seen primarily as a weight-loss company to one that is recognized as a leader in the broader field of metabolic health. It’s a shift to a far larger and more durable market, as we move from helping people not only lose weight but also helping them live metabolically healthier lives.
Learn More
Company Performance

Metabolic Synchronization

Metabolic Synchronization is Medifast's breakthrough science that reverses metabolic dysfunction with a targeted reset of the body’s metabolism. This new science leverages years of clinical evidence to deliver result beyond the number on the scale. Research shows the company’s comprehensive metabolic health system activates strong and targeted fat burn to improve metabolic health by reducing bad visceral fat, preserving lean mass and protecting muscle. This approach results in quality weight loss that goes beyond the scale, ultimately empowering individuals to reach their health goals.

Learn More
Company Performance

The Coach Component

Coaches play a vital role in translating the underlying science that powers our approach into real-world results that help people make a real difference in their approach to health.

Learn More
YEARS OF EXPERIENCE

40+ years

Backed by more than 40 years of experience, clinically proven plans, innovative products and a powerful integrated Coach model, Medifast is a publicly traded market leader by revenue in the U.S. $7 billion weight management industry. Our business model is differentiated and unique — a scalable Coach-based approach that drives both program effectiveness and company growth.

LIVES IMPACTED

3 million

OPTAVIA Coaches have impacted more than 3 million lives, supporting Clients in their journeys to optimal health and wellbeing.

HEALTHCARE RECOMMENDATIONS

Thousands

As a leader in the health and wellness industry, our clinically proven plans and scientifically designed products have been recommended to Clients for decades.

ACTIVE EARNING COACHES

Tens of Thousands

Medifast has built a network of thousands of independent active earning coaches who impact lives.

Our History 1981 Medifast is Founded

Medifast is founded, having created a proprietary formula for meal replacements distributed exclusively through doctors.

Our History 2002 Medifast Announces Listing on the American Stock Exchange

As a testament to its significant growth and success, the company goes public for the first time on the American Stock Exchange (AMEX). In 2006, Medifast joins the New York Stock Exchange (NYSE) as it continues to grow in sales and earnings.

Our History 2004 First Clinically Proven and Scientifically Designed Products Introduced

Medifast launches the 5 & 1 Plan along with the Lean & Green meal that offers an endless variety of protein and fresh veggie options to help Clients reach optimal health in delicious, new ways. The clinically proven Plan and scientifically designed products were developed by physicians, dietitians and scientists.

Our History 2008 Dr. A. Launches the Revolutionary Habits of Health® Transformational System

With Dr. A’s Habits of Health Transformational System, Clients learn to create healthy habits through small, daily changes called microHabits – often starting with achieving a healthy weight and focusing on healthy eating. It isn’t only about the food you eat, though. The program also addresses hydration, exercise, sleep, mindfulness and surroundings – with the goal of healthy habit creation in all areas of life.

Our History 2017 Introducing, OPTAVIA

There are three fundamental truths that we believe to be true: People are more successful in their health journey when they (1) have help from a Coach, (2) have the support of a Community and (3) incorporate healthy habits into their lives. These insights brought about the evolution of our brand and how we support people in their journey, now exclusively through the OPTAVIA integrated Coach model.

*Appel, L.J., et al., Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med, 2011. 365(21): p. 1959-68; Harrigan, M., et al., Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study. J Clin Oncol, 2016. 34(7): p. 669-76; van Wier M.F., et al., Phone and e-mail counselling are effective for weight management in an overweight working population: a randomized controlled trial. BMC Public Health, 2009. 9: 6; and Donnelly, J.E., et al., Comparison of a phone vs clinic approach to achieve 10% weight loss. Int J Obes (Lond), 2007. 31(8): p. 1270-6

Our History 2020 Medifast Rings the Bell
Medifast executive leadership – along with Co-Founder and independent OPTAVIA Coach Dr. Wayne Scott Andersen, along with other independent OPTAVIA Coaches – receive the honor of ringing the bell on the New York Stock Exchange. This moment symbolizes the Company’s outstanding accomplishments made possible by the dedication of the OPTAVIA Coach Community.
Our History 2021 A Billion-Dollar Company Impacts 2 Million Lives
Medifast’s fast-growing health and wellness community, OPTAVIA, achieves $1 billion in revenue**, joining an exclusive group of the world’s billion-dollar brands. Even more important is the human impact. Independent OPTAVIA Coaches, who support Clients along their journeys to optimal health and wellbeing, reached a monumental milestone – impacting more than 2 million lives. **Based on full year revenue as of Q3 2021.
Our History 2022 Medifast Product Innovation Center Grand Opening

Medifast announces the opening of a new research and development hub, the Medifast Product Innovation Center. The workplace is designed to support innovation as the company continues to expand its focus to help customers in critical health need-states, with or without medications.

Our History 2023 Medifast announces OPTAVIA ACTIVE product line

Medifast announces OPTAVIA ACTIVE, a new line of products scientifically designed to support muscle health and encourage the Habit of Healthy Motion, a key component of any health and wellness journey. Led by our company’s team of researchers, food scientists, nutritionists and other scientific experts, OPTAVIA ACTIVE Essential Amino Acid (EAA) Blend and OPTAVIA ACTIVE Whey Protein are designed to address muscle mass decline and support overall muscle health.

Our History 2024 Medifast Launches OPTAVIA ASCEND

Medifast introduces OPTAVIA ASCEND — a new product line of high-protein, fiber-rich mini meals as well as a daily nutrient pack. These products are featured in two new science-backed nutrition plans designed for people on GLP-1 medications and those looking for help to keep weight off. The mini meals provide essential nutrients to promote muscle health, digestive health and bone health, and combined with the new plans and OPTAVIA’s holistic offer, fill a critical gap in the weight management market.

SCIENTIFIC ADVISORY BOARD

Internationally Recognized Experts in Science and Health & Wellness

Medifast first formed their Scientific Advisory Board in 2008. It is comprised of internationally recognized experts, all of whom have made significant contributions in their respective field. The function of the Scientific Advisory Board is to provide objective insight and external expertise to help guide Medifast in making informed, evidence-based decisions on medical, nutritional and scientific matters. The Scientific Advisory Board serves as a part of our foundation to create scientifically valid, consumer-centric, high-quality innovations for lasting health.

This cross-disciplinary group consists of distinguished physicians, academic researchers, nutrition and health-related policy experts. The work of this prestigious board builds on Medifast’s scientific and clinical heritage, which focuses on sound approaches to weight management while exploring forward-looking innovations, product and program offerings, and clinical research opportunities.

**This website contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend,” “anticipate,” “expect” or other similar words or the negative of such terminology. Similarly, descriptions of Medifast’s objectives, strategies, plans, goals, outlook or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of the management of Medifast and are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Medifast’s inability to maintain and grow the network of independent OPTAVIA Coaches; Industry competition and new weight loss products, including weight loss medications, or services; Medifast’s health or advertising related claims by our OPTAVIA customers; effectiveness of Medifast’s advertising and marketing programs, including use of social media by OPTAVIA Coaches; Medifast’s inability to protect against online security risks and cyberattacks; risks associated with Medifast’s direct-to-consumer business model; disruptions in Medifast’s supply chain; Medifast’s planned growth into domestic markets; adverse publicity associated with Medifast’s products; the impact of existing and future laws and regulations on Medifast’s business; fluctuations of Medifast’s common stock market price; increases in litigation; actions of activist investors; the consequences of other geopolitical events, overall economic and market conditions and the resulting impact on consumer sentiment and spending patterns; and Medifast’s ability to prevent or detect a failure of internal control over financial reporting. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its most recent Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its quarterly reports on Form 10-Q and current reports on Form 8-K.